| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Eur J Cardiothorac Surg 2006;30:881-886
© 2006 Elsevier Science NL
a Department of Cardiothoracic Surgery, The University of Tokyo, Tokyo, Japan
b Department of Cardiology, The University of Tokyo, Tokyo, Japan
Received 2 July 2006; received in revised form 8 September 2006; accepted 25 September 2006.
* Corresponding author. Address: Department of Cardiothoracic Surgery, The University of Tokyo, 7-3-1, Hongo, Bunkyo-Ku, Tokyo 113-8655, Japan. Tel.: +81 3 5800 8654; fax: +81 3 5684 3989. (Email: takohno-tky{at}umin.net).
Objective: The presence of retinopathy is a predictor of mortality following coronary revascularization in diabetics. We studied whether revascularization by coronary-artery-bypass surgery (CABG), as compared with percutaneous coronary intervention (PCI), influences the prognosis in diabetics with retinopathy. Methods: Between April 1996 and March 2004, 1489 patients underwent revascularization as an initial procedure. Among these a total of 319 diabetics underwent retinal examination prior to the initial revascularization. These patients were classified according to whether they had retinopathy and whether they had undergone CABG, either initially or after PCI. Mortality rates were estimated from the time of initial revascularization procedure. Results: The average follow-up from the time of initial revascularization was 48.2 ± 28.6 months. In 153 diabetics with retinopathy, 59 eventually underwent CABG. During the entire follow-up period, there were 2 (3.4%) deaths in diabetics with retinopathy who underwent CABG and 14 (14.9%) deaths in those who did not have CABG. Mortality curves differed significantly between the two groups (P = 0.007). After adjustment for risk factors, the relative risk of death was 0.13 afforded by CABG (95% CI, 0.03–0.62; P = 0.011). In 166 diabetics without retinopathy, mortality curves were similar between the patients who underwent CABG and those who did not have CABG (P = 0.94). Conclusions: CABG conferred a survival advantage in diabetics with retinopathy. In contrast, no survival advantage was evident in diabetics without retinopathy undergoing CABG. Retinal status should be taken into consideration when considering revascularization strategy for diabetics who have coronary artery disease.
Key Words: Diabetic retinopathy • Coronary-artery-bypass surgery • Percutaneous coronary intervention • Survival • CABG • Surgery • Diabetes mellitus • Statistics • Survival analysis
This article has been cited by other articles:
|
|
 |
|
  T. Ohno, O. Kinoshita, H. Fujita, S. Kato, A. Hirose, T. Sigeeda, K. Otomo, J. Ando, T. Kadowaki, M. Araie, et al. Detecting occult coronary artery disease followed by early coronary artery bypass surgery in patients with diabetic retinopathy: Report from a diabetic retinocoronary clinic J. Thorac. Cardiovasc. Surg., January 1, 2010; 139(1): 92 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Cheung, J. J. Wang, S. L. Rogers, F. Brancati, R. Klein, A. R. Sharrett, T. Y. Wong, and for the ARIC (Atherosclerosis Risk In Communities) Diabetic retinopathy and risk of heart failure. J. Am. Coll. Cardiol., April 22, 2008; 51(16): 1573 - 1578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ohno, S. Takamoto, and N. Motomura Diabetic Retinopathy and Coronary Artery Disease From the Cardiac Surgeon's Perspective Ann. Thorac. Surg., February 1, 2008; 85(2): 681 - 689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ohno, S. Takamoto, N. Motomura, M. Ono, J. Ando, T. Morita, H. Fujita, Y. Hirata, R. Nagai, T. Shigeeda, et al. Coronary Artery Bypass Grafting Versus Coronary Implantation of Sirolimus-Eluting Stents in Patients with Diabetic Retinopathy Ann. Thorac. Surg., November 1, 2007; 84(5): 1474 - 1478. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
